Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_assertion description "[Fusion gene products such as PML-RARalpha and BCR-ABL generated by leukemia-specific chromosomal translocations have been identified as target molecules for the treatment of leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_assertion evidence source_evidence_literature NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_assertion SIO_000772 11587362 NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_assertion wasDerivedFrom befree-2016 NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_assertion wasGeneratedBy ECO_0000203 NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.
- befree-2016 importedOn "2016-02-19" NP332047.RA_3NaEh7gP8v1Vm8v31laEtmWk8bCgJcIPemYZd8wAY0130_provenance.